CLINICAL_TRIALS trial_result · 2024-06-28

Clinical Trial Update: Repurposing Anti-TNF for Treating Dupuytren's Disease [Phase 2]

A Phase 2 trial evaluating repurposing an anti-TNF therapy for Dupuytren's disease has completed, and results were posted on 2024-06-28.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Oxford | Conditions: Dupuytren's Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-06-28